Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paresh Jobanputra

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Rheumatology and Therapy|October 18, 2016
Consensus Decision Models for Biologics in Rheumatoid and Psoriatic Arthritis: Recommendations of a Multidisciplinary Working PartyJason Madan, Tony Ades, Pelham Barton, et al.
BMJ Open|November 14, 2012
A randomised efficacy and discontinuation study of etanercept versus adalimumab (RED SEA) for rheumatoid arthritis: a pragmatic, unblinded, non-inferiority study of first TNF inhibitor use: outcomes over 2 yearsParesh Jobanputra, Fiona Maggs, Alison Deeming, et al.
Annals of the Rheumatic Diseases|February 12, 2017
Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS)Ariane L Herrick, Xiaoyan Pan, Sébastien Peytrignet, et al.
Annals of the Rheumatic Diseases|January 8, 2018
Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational StudyAriane L Herrick, Sebastien Peytrignet, Mark Lunt, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Rheumatology and Therapy|October 18, 2016
Consensus Decision Models for Biologics in Rheumatoid and Psoriatic Arthritis: Recommendations of a Multidisciplinary Working PartyJason Madan, Tony Ades, Pelham Barton, et al.
BMJ Open|November 14, 2012
A randomised efficacy and discontinuation study of etanercept versus adalimumab (RED SEA) for rheumatoid arthritis: a pragmatic, unblinded, non-inferiority study of first TNF inhibitor use: outcomes over 2 yearsParesh Jobanputra, Fiona Maggs, Alison Deeming, et al.
Annals of the Rheumatic Diseases|February 12, 2017
Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS)Ariane L Herrick, Xiaoyan Pan, Sébastien Peytrignet, et al.
Annals of the Rheumatic Diseases|January 8, 2018
Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational StudyAriane L Herrick, Sebastien Peytrignet, Mark Lunt, et al.
Pageof 3